Located in Cambridge’s Kendall Square neighborhood, in the heart of the Boston/Cambridge life sciences corridor, the MESC is near some of the world’s leading academic institutions, research hospitals, many other biotechnology and pharmaceutical companies, and Merck's Boston discovery research site, which opened in 2004.
This Merck outpost aims to explore emerging areas of disease biology to uncover new opportunities for drug discovery research.
The MESC is made up of approximately 40 accomplished researchers with diverse scientific backgrounds but one common goal: To bring together biology, chemistry, technology and drug discovery under one roof to ultimately help MRL’s global network of researchers to discover and develop new and innovative medicines and vaccines.
Scientists here are using their curiosity and creativity to help us better understand how diseases operate. This helps identify new potential targets for our drug and vaccine discovery research. Their research activities include identifying:
- How infectious organisms (pathogens) interact with host cells
- Microbiome (collection of micro-organisms residing in and on the body) response
- Underlying biology of diseases